Gentherm (THRM) Q2 2026 earnings review
Record Revenue and a Massive $400M Buyback Overshadow Margin Pressures
Gentherm delivered a decisive top-line beat in Q2, generating record quarterly revenue of $416.2M (+11.0% YoY), aggressively outpacing the broader light vehicle market. The company raised its full-year guidance across the board and, in a major show of confidence, authorized a massive $400M stock repurchase program. However, profitability metrics tell a bumpier story: Adjusted EBITDA margins compressed to 11.7% from 12.2% a year ago, validating management's prior warnings about mid-year inflationary headwinds. Cash flow was also severely drained by restructuring and M&A costs. Investors must weigh accelerating sales and capital returns against near-term margin friction and integration execution risk.
🐂 Bull Case
The Board authorized a new $400M stock repurchase program. For a company of Gentherm's size, this represents a highly aggressive commitment to capital return and signals strong conviction in future cash flows, despite current quarter M&A noise.
Automotive Climate and Comfort Solutions revenue grew 14.1% YoY (12.7% ex-FX). Management explicitly noted this outperformed S&P Global’s light vehicle production report by a staggering 14 percentage points, proving they are capturing significant content-per-vehicle gains.
🐻 Bear Case
Gross margin dropped 70 basis points to 23.2%, driven by higher material costs and warranty accruals. The margin squeeze management warned about in Q1 is actively hitting the bottom line.
Operating cash flow plunged from $31.7M in 25Q2 to just $2.3M this quarter. While management points to restructuring and M&A expenses (the Modine transaction), the cash drain creates a weaker optical bridge into the second half of the year.
⚖️ Verdict: 🟢
Bullish. The top-line acceleration is structural and the 14-point market outperformance is exceptional. While margin compression and cash drain are concerns, they were previously telegraphed. The raised guidance and enormous $400M buyback authorization demonstrate management's confidence in near-term cash generation and the Modine integration.
Key Themes
Lumbar and Massage Comfort Solutions Surge
The Lumbar and Massage segment continues to be Gentherm's primary growth engine. Revenue exploded 38.2% YoY to $72.6M in Q2. This validates the strategic push to integrate proprietary Puls.A technology across both luxury and mass-market platforms. This segment alone added $20M in incremental revenue YoY, accounting for nearly half of the company's total product revenue growth.
Inflation and Warranty Costs Bite Gross Margins
Gross margin dropped from 23.9% to 23.2% YoY. Management attributed this directly to 'higher material costs, including higher warranty accruals in Automotive and Medical.' In Q1, management warned of a $20M gross cost headwind from logistics and raw materials affecting Q2 and Q3; this print confirms that pain is real and currently outpacing commercial recovery efforts.
Strategic Medical Acquisition to Revive Stagnant Segment
The Medical segment has been a persistent laggard, growing just 1.0% YoY this quarter (and shrinking 0.2% ex-FX). To combat this, Gentherm acquired Innovative Medical Equipment, LLC, the provider of the ThermaZone thermal therapy device. This immediately broadens the portfolio and provides new cross-selling channels, which management desperately needs to achieve its long-term goal of doubling the Medical business.
Operating Cash Flow Collapse
Operating cash flow for the quarter was a paltry $2.3M, a severe deceleration from $31.7M in the prior year. The difference was heavily driven by $27.6M in M&A expenses year-to-date (related to the Modine transaction) and a massive $58.1M build in Accounts Receivable. While AR buildup often accompanies record revenue, this level of cash absorption requires close monitoring in H2.
Non-Automotive 'Adjacent Market' Scaling Rapidly
Gentherm's strategy to port auto-tech into new markets is gaining tangible momentum. The company secured business with two new North American furniture brands in Q2—marking the fourth consecutive quarter of landing new home and office customers. This capital-light growth vector is accelerating exactly as management promised during their Q1 push to reach $50M-$100M in furniture revenue by 2028.
Navigating a Declining Macro Auto Market
Gentherm is modeling its raised 2026 guidance against a backdrop of light vehicle production in relevant markets 'decreasing at a low single digit rate.' Delivering double-digit revenue growth against a contracting macro environment speaks volumes to the company's content-per-vehicle expansion and market share conquests.
M&A Integration Demands Reaching Peak Complexity
Gentherm is currently juggling the massive Modine Performance Technologies combination (on track to close early Q4), completing global footprint realignments, and integrating the newly acquired ThermaZone business. M&A execution risk is elevated, as evidenced by the $12.8M in merger expenses dragging down this quarter's profitability.
Other KPIs
Accelerated significantly from $0.54 in the prior year. A major driver of optically higher net income was the non-recurrence of a massive $17.4M foreign currency loss that crushed the Q2 2025 results.
Despite funding acquisitions and restructuring, the balance sheet remains exceptionally clean. Liquidity stands at over $502M, providing ample firepower for the newly authorized $400M stock repurchase program.
Guidance
Accelerating. Raised from the prior range of $1.5B - $1.6B. At the $1.6B midpoint, this implies approximately 6.8% YoY growth over FY25's $1.498B. Crucially, this guidance absorbs an expected low-single-digit decline in the broader auto market.
Accelerating. Raised from $175M - $195M. The new midpoint of $192.5M implies an Adjusted EBITDA margin of roughly 12.0%. Given H1 generated $98.1M, the guidance implies a relatively balanced H2, requiring execution on commercial pricing negotiations to offset the ongoing inflation drag.
Raised from $80M - $100M. The company has only generated $15.8M of Adjusted FCF in the first half of the year. Hitting the $92.5M midpoint will require a massive step-up in H2 cash generation and stabilization of the working capital (Accounts Receivable) build seen in Q2.
Key Questions
Margin Recovery Cadence
Gross margins were squeezed by warranty and material costs. How much of the Q2 warranty headwind is a one-time true-up versus an ongoing elevated run-rate? How are commercial price recovery negotiations progressing to offset the $20M inflation impact expected this year?
Pacing the $400M Buyback
A $400M authorization is highly material. How aggressive will the execution be in the near term, especially given the impending closure of the Modine transaction in early Q4? Will debt be utilized to accelerate repurchases?
Working Capital Dynamics
Operating cash flow was unusually light this quarter, impacted by a large build in accounts receivable. Is this purely a function of back-end loaded quarter shipments, or are there changing payment terms and collection dynamics with key OEMs?
ThermaZone Integration Strategy
With the acquisition of Innovative Medical Equipment, what is the anticipated timeline for integrating the ThermaZone device into your sales channels, and when will the Medical segment realistically return to double-digit organic growth?